ArticleInvestigative and clinical urology2025
DRG2 levels in prostate cancer cell lines predict response to PARP inhibitor during docetaxel treatment.
Jeong Min Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it